Janux Therapeutics Inc header image

Janux Therapeutics Inc

JANX

Equity

ISIN null / Valor 111742522

NASDAQ (2026-11-10)
USD 12.04-5.64%

Janux Therapeutics Inc
UMushroom community rating:

star star star star star
3.47 45 votes No rating yet
NegativeNeutralPositive

About company

Janux Therapeutics Inc., founded in 2017, is a biotechnology company focused on developing innovative immunotherapies for cancer treatment. The company leverages its proprietary technology to create next-generation T cell engagers designed to target and eliminate cancer cells while minimizing damage to healthy tissues. Janux successfully completed its initial public offering (IPO) in June 2021 and advanced its first therapeutic program to clinical trials in the latter half of 2022. The company's approach emphasizes a collaborative and data-driven culture to foster scientific innovation and accelerate the development of its therapeutic pipeline.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-56.4%1Y
99.3%3Y
-49.6%5Y

Performance

91.4%1Y
107%3Y
96.6%5Y

Volatility

Market cap

736 M

Market cap (USD)

Daily traded volume (Shares)

2,354,816

Daily traded volume (Shares)

1 day high/low

53.71 / 52.27

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.47

45 votes
Performance:
starstarstarstarstar
3.51
Innovation:
starstarstarstarstar
3.67
Society:
starstarstarstarstar
3.51
Nature:
starstarstarstarstar
3.29
Aiman Harith Muhaimin Agos Sawal
UK, 18 May 2026
star star star star star
Hard fall
Jakub Wrona
Switzerland, 23 Mar 2026
star star star star star
Goof
Thomas Chamier
UK, 03 Mar 2026
star star star star star
Way too Volatile

EQUITIES OF THE SAME SECTOR

STERIS PLC
STERIS PLC STERIS PLC Valor: 47027903
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 257.12
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.39%CHF 71.20
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.48%USD 206.35
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 1.07
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC Valor: 14769757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.77%USD 245.43
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.42%USD 30.92
Addex Therapeutics Ltd
Addex Therapeutics Ltd Addex Therapeutics Ltd Valor: 2985075
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.93%CHF 0.022
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 523134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.92%USD 22.74
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited Valor: 12029898
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.42%INR 1,905.00
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.40%INR 1,017.95